Literature DB >> 14762797

Antibody responses in Crohn's disease.

Séverine Vermeire, Paul Rutgeerts.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14762797     DOI: 10.1053/j.gastro.2003.12.020

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  5 in total

Review 1.  Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: a systematic review and meta-analysis.

Authors:  Amit Kaul; Susan Hutfless; Ling Liu; Theodore M Bayless; Michael R Marohn; Xuhang Li
Journal:  Inflamm Bowel Dis       Date:  2012-01-31       Impact factor: 5.325

2.  Serum antibodies to Mycobacterium avium subspecies paratuberculosis combined with anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients: prevalence and diagnostic role.

Authors:  Franck Biet; Laurent Gendt; Eric Anton; Eric Ballot; Jean-Pierre Hugot; Catherine Johanet
Journal:  Dig Dis Sci       Date:  2011-01-08       Impact factor: 3.199

3.  New serological markers in inflammatory bowel disease are associated with complicated disease behaviour.

Authors:  Marc Ferrante; Liesbet Henckaerts; Marie Joossens; Marie Pierik; Sofie Joossens; Nir Dotan; Gary L Norman; Rom T Altstock; Kristel Van Steen; Paul Rutgeerts; Gert Van Assche; Séverine Vermeire
Journal:  Gut       Date:  2007-04-24       Impact factor: 23.059

4.  Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activation.

Authors:  H Takedatsu; K D Taylor; L Mei; D P B McGovern; C J Landers; R Gonsky; Y Cong; E A Vasiliauskas; A Ippoliti; C O Elson; J I Rotter; S R Targan
Journal:  Gut       Date:  2008-10-02       Impact factor: 23.059

Review 5.  Therapeutic potential of tolerogenic dendritic cells in IBD: from animal models to clinical application.

Authors:  Raquel Cabezón; Daniel Benítez-Ribas
Journal:  Clin Dev Immunol       Date:  2013-11-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.